The Clorox Company $CLX Shares Newly Purchased by Bill Few Associates Inc.

Key Points

• Bill Few Associates purchased 11,988 Clorox shares worth approximately $971,000 in the third quarter, while institutional investors collectively own 78.53% of the company.
• Clorox reported quarterly EPS of $1.66, slightly exceeding estimates, but revenue declined 2% year over year to $1.95 billion. The stock recently traded at $83.75, near its 52-week low.
• Clorox declared a quarterly dividend of $1.25, or $5.00 annualized, yielding about 6%; however, analysts maintain a generally negative outlook, with an average rating of “Reduce” and a $99.36 price target.

Bill Few Associates Inc. bought a new stake in The Clorox Company (NYSE:CLX - Free Report) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 11,988 shares of the company's stock, valued at approximately $971,000.

Several other institutional investors also recently made changes to their positions in the stock. BlackRock Inc. bought a new stake in shares of Clorox in the 2nd quarter worth approximately $958,640,000. Bank of America Corp DE acquired a new stake in Clorox in the second quarter worth $179,780,000. Bank of New York Mellon Corp bought a new stake in Clorox in the second quarter valued at $123,154,000. Equity Investment Corp bought a new stake in Clorox in the second quarter valued at $111,800,000. Finally, Deutsche Bank AG acquired a new position in shares of Clorox during the second quarter valued at $68,473,000. 78.53% of the stock is owned by institutional investors.

Clorox Price Performance

CLX stock traded up $0.31 during trading on Friday, hitting $83.75. The company had a trading volume of 1,497,905 shares, compared to its average volume of 2,657,298. The business has a 50 day moving average of $94.36 and a 200 day moving average of $96.01. The firm has a market capitalization of $10.13 billion, a price-to-earnings ratio of 17.38, a P/E/G ratio of 2.59 and a beta of 0.59. The company has a current ratio of 0.66, a quick ratio of 0.38 and a debt-to-equity ratio of 15.80. The Clorox Company has a fifty-two week low of $79.12 and a fifty-two week high of $128.90.

Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Monday, August 3rd. The company reported $1.66 EPS for the quarter, beating the consensus estimate of $1.64 by $0.02. Clorox had a net margin of 8.74% and a return on equity of 522.23%. The firm had revenue of $1.95 billion for the quarter, compared to analysts' expectations of $1.91 billion. During the same quarter last year, the company earned $2.87 EPS. Clorox's quarterly revenue was down 2.0% on a year-over-year basis. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. As a group, research analysts predict that The Clorox Company will post 5.77 earnings per share for the current year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Wednesday, October 28th will be paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 6.0%. The ex-dividend date of this dividend is Wednesday, October 28th. Clorox's payout ratio is currently 103.73%.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on CLX. Jefferies Financial Group cut shares of Clorox from a "buy" rating to a "hold" rating and dropped their price objective for the stock from $125.00 to $98.00 in a report on Tuesday, July 28th. Evercore set a $99.00 target price on shares of Clorox in a research report on Tuesday, August 4th. Wells Fargo & Company dropped their price target on shares of Clorox from $90.00 to $85.00 and set an "equal weight" rating on the stock in a research note on Monday. BNP Paribas Exane cut their price target on Clorox from $97.00 to $95.00 and set a "neutral" rating on the stock in a report on Monday, July 20th. Finally, Citigroup reduced their price objective on Clorox from $100.00 to $97.00 and set a "neutral" rating for the company in a research report on Friday, September 11th. Twelve analysts have rated the stock with a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat.com, Clorox currently has an average rating of "Reduce" and an average target price of $99.36.

About Clorox

The Clorox Company is a consumer and professional products company that develops, manufactures and markets household cleaning, disinfecting, wellness and personal care products. Its portfolio includes the Clorox bleach and cleaning brands, as well as products sold under brands such as Pine-Sol, Liquid-Plumr, Fresh Step, Scoop Away, Kingsford, Hidden Valley, Burt's Bees and Brita.

Clorox also offers trash bags, food products, water-filtration systems, charcoal and grilling products, cat litter, and professional cleaning and disinfecting solutions.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.